首页> 外文期刊>Genetic epidemiology. >Genomewide linkage scan reveals novel loci modifying age of onset of Huntington's disease in the Venezuelan HD kindreds.
【24h】

Genomewide linkage scan reveals novel loci modifying age of onset of Huntington's disease in the Venezuelan HD kindreds.

机译:全基因组连锁扫描揭示了在委内瑞拉高清亲戚中改变亨廷顿氏病发病年龄的新基因座。

获取原文
获取原文并翻译 | 示例
           

摘要

The age of onset of Huntington's disease (HD) is inversely correlated with the CAG length in the HD gene. The CAG repeat length accounts for 70% of the variability in HD age of onset. However, 90% of individuals worldwide with expanded alleles possess between 40 and 50 CAG repeat lengths in their HD gene. For these people, the size of their repeat only determines 44% of the variability in their age of onset. Once the effect of the CAG repeat has been accounted for, the residual variance in age of onset is a heritable trait. Targeted candidate gene studies and a genome scan have suggested some loci as potential modifiers of the age of onset of HD. We analyzed the large Venezuelan kindreds in which the HD gene was originally identified. These kindreds offer greater analytic power than standard sib-pair designs. We developed novel pedigree-member selection procedures to maximize power. Using a 5,858-single-nucleotide-polymorphism marker panel, we performed a genomewide linkage analysis. We discovered two novel loci on chromosome 2. Chromosome 2p25 (logarithm of the odds ratio (LOD)=4.29) and 2q35 (LOD=3.39) may contain genes that modify age of onset. A third linkage peak on chromosome 6q22 (LOD=2.48) may confirm the most promising locus from a previous genome scan. Two other candidate loci are suggestive on chromosome 5 (LOD=3.31 at 5p14 and LOD=3.14 at 5q32). All these regions harbor candidate genes that are potential HD modifier genes. Finding these modifier genes can reveal accessible and promising new therapeutic pathways and targets to ameliorate and cure HD.
机译:亨廷顿舞蹈病(HD)的发病年龄与HD基因中的CAG长度成反比。 CAG重复长度占HD发病年龄变异性的70%。但是,全世界90%具有扩展等位基因的个体在其HD基因中具有40至50个CAG重复长度。对于这些人,其重复次数仅决定发病年龄变异性的44%。一旦考虑了CAG重复的影响,发病年龄的残余变异就是可遗传的特征。有针对性的候选基因研究和基因组扫描表明,某些基因座可作为HD发病年龄的潜在修饰因子。我们分析了最初鉴定HD基因的大型委内瑞拉血统。这些同类产品提供比标准同胞对设计更高的分析能力。我们开发了新颖的谱系成员选择程序以最大程度地发挥力量。使用5,858个单核苷酸多态性标记物面板,我们进行了全基因组连锁分析。我们在2号染色体上发现了两个新基因座。2p25染色体(优势比(LOD)的对数= 4.29)和2q35(LOD = 3.39)可能含有改变发病年龄的基因。染色体6q22上的第三个连锁峰(LOD = 2.48)可能证实了先前基因组扫描中最有希望的基因座。另外两个候选基因座在5号染色体上具有暗示性(5p14的LOD = 3.31,5q32的LOD = 3.14)。所有这些区域都含有潜在的HD修饰基因的候选基因。发现这些修饰基因可以揭示可改善的和有希望的新治疗途径和靶标,以改善和治愈HD。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号